Related Experiment Video
Updated: Apr 14, 2026
10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
11.2K
Vitamin D testing in pregnancy: Does one size fit all?
Miranda Davies-Tuck1, Cheryl Yim, Michelle Knight
1The Ritchie Centre, MIMR-PHI Institute of Medical Research, Clayton, Vic., Australia; Department of Obstetrics and Gynaecology, School of Clinical Sciences, Monash University, Clayton, Vic., Australia.
Summary
Vitamin D deficiency is prevalent in pregnant women, affecting over half. However, routine testing for vitamin D in pregnancy is not recommended as deficiency is not linked to most adverse outcomes.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Nutritional Science
Background:
- Vitamin D deficiency is a widespread concern.
- Optimal vitamin D levels during pregnancy and the benefits of supplementation are debated.
- Prevalence of vitamin D deficiency in pregnant populations requires further investigation.
Purpose of the Study:
- To evaluate vitamin D status in pregnant women undergoing routine antenatal screening.
- To examine the association between early pregnancy vitamin D levels and pregnancy outcomes.
- To assess the relationship between changes in vitamin D levels throughout pregnancy and maternal/fetal health.
Main Methods:
- Serum vitamin D concentrations were measured in early and late pregnancy.
- Statistical analyses were performed to estimate relationships between vitamin D status, maternal factors, and pregnancy outcomes.
- Changes in vitamin D levels over the course of pregnancy were quantified and analyzed.
Main Results:
- Over half of pregnant women (55%) were vitamin D deficient (<50 nmol/L) in early pregnancy.
- Vitamin D deficiency was associated with higher BMI, winter/spring pregnancies, and specific maternal countries of birth.
- Early pregnancy vitamin D deficiency/insufficiency was linked to gestational diabetes mellitus, but not most other adverse outcomes.
Conclusions:
- Vitamin D deficiency is common in pregnancy but not strongly associated with most adverse pregnancy outcomes.
- Routine vitamin D testing for all pregnant women is not supported by current evidence.
- Further research may clarify the specific benefits of vitamin D supplementation in certain high-risk groups.
Related Concept Videos
01:23Role of Skin in Vitamin D Synthesis
9.0K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
9.0K
01:30Vitamins
3.1K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.1K
01:07Teratogenicity
4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
319
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
319
01:22Diabetes Mellitus: Type 2 and Gestational
5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K